Depressive symptoms in cognitively unimpaired older adults are associated with lower structural and functional integrity in a frontolimbic network.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
12 2022
Historique:
received: 25 09 2021
accepted: 30 08 2022
revised: 19 08 2022
pubmed: 19 10 2022
medline: 22 12 2022
entrez: 18 10 2022
Statut: ppublish

Résumé

Subclinical depressive symptoms are associated with increased risk of Alzheimer's disease (AD), but the brain mechanisms underlying this relationship are still unclear. We aimed to provide a comprehensive overview of the brain substrates of subclinical depressive symptoms in cognitively unimpaired older adults using complementary multimodal neuroimaging data. We included cognitively unimpaired older adults from the baseline data of the primary cohort Age-Well (n = 135), and from the replication cohort ADNI (n = 252). In both cohorts, subclinical depressive symptoms were assessed using the 15-item version of the Geriatric Depression Scale; based on this scale, participants were classified as having depressive symptoms (>0) or not (0). Voxel-wise between-group comparisons were performed to highlight differences in gray matter volume, glucose metabolism and amyloid deposition; as well as white matter integrity (only available in Age-Well). Age-Well participants with subclinical depressive symptoms had lower gray matter volume in the hippocampus and lower white matter integrity in the fornix and the posterior parts of the cingulum and corpus callosum, compared to participants without symptoms. Hippocampal atrophy was recovered in ADNI, where participants with subclinical depressive symptoms also showed glucose hypometabolism in the hippocampus, amygdala, precuneus/posterior cingulate cortex, medial and dorsolateral prefrontal cortex, insula, and temporoparietal cortex. Subclinical depressive symptoms were not associated with brain amyloid deposition in either cohort. Subclinical depressive symptoms in ageing are linked with neurodegeneration biomarkers in the frontolimbic network including brain areas particularly sensitive to AD. The relationship between depressive symptoms and AD may be partly underpinned by neurodegeneration in common brain regions.

Identifiants

pubmed: 36258017
doi: 10.1038/s41380-022-01772-8
pii: 10.1038/s41380-022-01772-8
pmc: PMC9763117
doi:

Types de publication

Review Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

5086-5095

Subventions

Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Organisme : CIHR
Pays : Canada

Investigateurs

Eider M Arenaza-Urquijo (EM)
Florence Allais (F)
Claire André (C)
Julien Asselineau (J)
Sebastian Baez Lugo (S)
Martine Batchelor (M)
Axel Beaugonin (A)
Alexandre Bejanin (A)
Pierre Champetier (P)
Anne Chocat (A)
Fabienne Collette (F)
Sophie Dautricourt (S)
Eglantine Ferrand-Devouge (E)
Robin De Flores (R)
Vincent De La Sayette (V)
Pascal Delamillieure (P)
Marion Delarue (M)
Yacila I Deza-Araujo (YI)
Hélène Esperou (H)
Francesca Felisatti (F)
Eric Frison (E)
Francis Gheysen (F)
Julie Gonneaud (J)
Marc Heidmann (M)
Thien Huong Tran (T)
Frank Jessen (F)
Pierre Krolak-Salmon (P)
Gwendoline Le Du (G)
Valérie Lefranc (V)
Antoine Lutz (A)
Jose-Luis Molinuevo (JL)
Cassandre Palix (C)
Léo Paly (L)
Géraldine Rauchs (G)
Stéphane Réhel (S)
Florence Requier (F)
Eric Salmon (E)
Raquel Sanchez (R)
Corinne Schimmer (C)
Matthieu Vanhoutte (M)
Patrik Vuilleumier (P)
Caitlin Ware (C)
Miranka Wirth (M)

Informations de copyright

© 2022. The Author(s).

Références

J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Magn Reson Imaging. 2013 Jul;31(6):840-6
pubmed: 23602730
Am J Geriatr Psychiatry. 2013 Feb;21(2):184-95
pubmed: 23343492
J Geriatr Psychiatry Neurol. 2019 Jan 10;:891988718824036
pubmed: 30630387
Hum Brain Mapp. 2017 Feb;38(2):631-643
pubmed: 27623046
Neurobiol Aging. 2011 Dec;32(12):2322.e5-18
pubmed: 20619504
J Alzheimers Dis. 2015;46(1):63-73
pubmed: 25697700
Am J Geriatr Psychiatry. 2010 Jul;18(7):634-42
pubmed: 20220594
Am J Geriatr Psychiatry. 2013 Jul;21(7):685-95
pubmed: 23567400
Biol Psychiatry. 2011 Jul 15;70(2):191-7
pubmed: 21641582
Psychiatry Res Neuroimaging. 2021 Oct 30;316:111353
pubmed: 34390952
J Magn Reson Imaging. 2008 Dec;28(6):1345-50
pubmed: 19025941
J Alzheimers Dis. 2020;74(4):1045-1055
pubmed: 32144985
Neurology. 2002 Aug 13;59(3):364-70
pubmed: 12177369
Transl Psychiatry. 2019 Aug 5;9(1):188
pubmed: 31383842
Int Psychogeriatr. 2018 Feb;30(2):245-251
pubmed: 29198244
J Geriatr Psychiatry Neurol. 2014 Mar;27(1):5-12
pubmed: 24381233
Neural Plast. 2013;2013:639430
pubmed: 23577273
Am J Epidemiol. 2014 Aug 15;180(4):385-93
pubmed: 25086051
Front Aging Neurosci. 2014 Sep 11;6:241
pubmed: 25309426
J Affect Disord. 2018 Mar 15;229:269-274
pubmed: 29329059
Aging Ment Health. 2019 Jul;23(7):819-830
pubmed: 29381390
Behav Brain Sci. 2012 Jun;35(3):121-43
pubmed: 22617651
Am J Psychiatry. 2018 Jun 1;175(6):530-537
pubmed: 29325447
J Affect Disord. 2013 Jan 25;144(3):263-8
pubmed: 23141669
J Neurosci. 2005 Aug 24;25(34):7709-17
pubmed: 16120771
Am J Geriatr Psychiatry. 2007 Mar;15(3):214-23
pubmed: 17213374
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
J Affect Disord. 2016 Sep 15;202:1-9
pubmed: 27253210
Int J Geriatr Psychiatry. 2016 Aug;31(8):920-8
pubmed: 26766490
BMC Psychiatry. 2016 Jul 07;16:219
pubmed: 27389007
Neuroimage Clin. 2016 Dec 18;13:415-427
pubmed: 28116234
Am J Geriatr Psychiatry. 2016 Nov;24(11):1095-1104
pubmed: 27426238
Neurosci Biobehav Rev. 2018 Sep;92:104-127
pubmed: 29753752
Neurology. 2010 Jan 19;74(3):201-9
pubmed: 20042704
Neurobiol Aging. 2013 Jun;34(6):1662-73
pubmed: 23290588
Alzheimers Dement (N Y). 2018 Dec 14;4:714-723
pubmed: 30581977
Int J Geriatr Psychiatry. 2017 Apr;32(4):455-463
pubmed: 27114112
J Affect Disord. 2016 Nov 01;204:219-25
pubmed: 27372409
Int J Geriatr Psychiatry. 2009 Aug;24(8):809-19
pubmed: 19484709
Lancet Neurol. 2011 Sep;10(9):819-28
pubmed: 21775213
Neuroimage Clin. 2013 Aug 14;3:155-62
pubmed: 24179859
Alzheimers Dement (N Y). 2017 Aug 05;3(3):440-449
pubmed: 29067350
BMC Psychiatry. 2012 Oct 30;12:181
pubmed: 23110575
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Neuroimage Clin. 2014 Mar 12;4:481-7
pubmed: 24818074
Alzheimers Dement (Amst). 2017 Apr 18;8:73-85
pubmed: 28560308
Int J Geriatr Psychiatry. 2014 Dec;29(12):1173-84
pubmed: 24798480
J Alzheimers Dis. 2017;58(4):1273-1281
pubmed: 28550256
Front Aging Neurosci. 2018 Feb 20;10:40
pubmed: 29515435
J Affect Disord. 2011 Mar;129(1-3):126-42
pubmed: 20926139
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
J Affect Disord. 2020 Sep 1;274:262-268
pubmed: 32469814
J Affect Disord. 2012 Jun;139(1):56-65
pubmed: 22425432
Ann N Y Acad Sci. 2014 May;1316:29-52
pubmed: 24502540
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Psychol Med. 2015 Jul;45(9):1931-44
pubmed: 25896060
Curr Alzheimer Res. 2016;13(5):475-86
pubmed: 26971944
Arch Gen Psychiatry. 2006 Mar;63(3):273-9
pubmed: 16520432
Psychiatry Res Neuroimaging. 2020 Jan 30;295:111020
pubmed: 31790922
Int J Geriatr Psychiatry. 2011 Nov;26(11):1109-18
pubmed: 21370276
Acta Psychiatr Scand. 2006 Dec;114(6):398-410
pubmed: 17087788
Front Hum Neurosci. 2014 Jan 21;7:930
pubmed: 24478665
Biol Psychiatry. 2013 Sep 1;74(5):340-7
pubmed: 23290495
J Alzheimers Dis. 2016 Jul 14;53(4):1609-16
pubmed: 27447426
J Psychiatry Neurosci. 2009 Sep;34(5):367-75
pubmed: 19721847
Acta Psychiatr Scand. 2017 Jan;135(1):78-86
pubmed: 27800603
Lancet Neurol. 2015 Oct;14(10):1037-53
pubmed: 26318837
J Alzheimers Dis. 2017;59(3):975-985
pubmed: 28697559
Alzheimers Dement. 2020 Jul;16(7):1054-1064
pubmed: 32508019
J Pers Soc Psychol. 2003 Aug;85(2):348-62
pubmed: 12916575
Psychiatry Res. 2014 Nov 30;224(2):73-80
pubmed: 25205441
Brain. 2010 Nov;133(11):3301-14
pubmed: 20688814
Neuropsychopharmacology. 2014 Feb;39(3):770-9
pubmed: 24220026
Biol Psychiatry. 2017 Sep 1;82(5):339-350
pubmed: 28318491
J Neurophysiol. 2011 Sep;106(3):1125-65
pubmed: 21653723

Auteurs

Edelweiss Touron (E)

Unité 1237 PhIND "Physiopathology and Imaging of Neurological Disorders", Institut National de la Santé et de la Recherche Médicale, Blood and Brain @ Caen-Normandie, GIP Cyceron, Normandie Université, Université de Caen, Caen, France.

Inès Moulinet (I)

Unité 1237 PhIND "Physiopathology and Imaging of Neurological Disorders", Institut National de la Santé et de la Recherche Médicale, Blood and Brain @ Caen-Normandie, GIP Cyceron, Normandie Université, Université de Caen, Caen, France.

Elizabeth Kuhn (E)

Unité 1237 PhIND "Physiopathology and Imaging of Neurological Disorders", Institut National de la Santé et de la Recherche Médicale, Blood and Brain @ Caen-Normandie, GIP Cyceron, Normandie Université, Université de Caen, Caen, France.

Siya Sherif (S)

Unité 1237 PhIND "Physiopathology and Imaging of Neurological Disorders", Institut National de la Santé et de la Recherche Médicale, Blood and Brain @ Caen-Normandie, GIP Cyceron, Normandie Université, Université de Caen, Caen, France.

Valentin Ourry (V)

Unité 1237 PhIND "Physiopathology and Imaging of Neurological Disorders", Institut National de la Santé et de la Recherche Médicale, Blood and Brain @ Caen-Normandie, GIP Cyceron, Normandie Université, Université de Caen, Caen, France.
Unité 1077 NIMH "Neuropsychologie et Imagerie de la Mémoire Humaine," Institut National de la Santé et de la Recherche Médicale, Normandie Université, Université de Caen, PSL Université, EPHE, CHU de Caen-Normandie, GIP Cyceron, Caen, France.

Brigitte Landeau (B)

Unité 1237 PhIND "Physiopathology and Imaging of Neurological Disorders", Institut National de la Santé et de la Recherche Médicale, Blood and Brain @ Caen-Normandie, GIP Cyceron, Normandie Université, Université de Caen, Caen, France.

Florence Mézenge (F)

Unité 1237 PhIND "Physiopathology and Imaging of Neurological Disorders", Institut National de la Santé et de la Recherche Médicale, Blood and Brain @ Caen-Normandie, GIP Cyceron, Normandie Université, Université de Caen, Caen, France.

Denis Vivien (D)

Unité 1237 PhIND "Physiopathology and Imaging of Neurological Disorders", Institut National de la Santé et de la Recherche Médicale, Blood and Brain @ Caen-Normandie, GIP Cyceron, Normandie Université, Université de Caen, Caen, France.
Département de Recherche Clinique, CHU de Caen-Normandie, Caen, France.

Olga M Klimecki (OM)

Clinical Psychology and Behavioral Neuroscience, Faculty of Psychology, Technische Universität Dresden, 01187, Dresden, Germany.

Géraldine Poisnel (G)

Unité 1237 PhIND "Physiopathology and Imaging of Neurological Disorders", Institut National de la Santé et de la Recherche Médicale, Blood and Brain @ Caen-Normandie, GIP Cyceron, Normandie Université, Université de Caen, Caen, France.

Natalie L Marchant (NL)

Division of Psychiatry, University College London, London, UK.

Gaël Chételat (G)

Unité 1237 PhIND "Physiopathology and Imaging of Neurological Disorders", Institut National de la Santé et de la Recherche Médicale, Blood and Brain @ Caen-Normandie, GIP Cyceron, Normandie Université, Université de Caen, Caen, France. chetelat@cyceron.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH